Company Filing History:
Years Active: 1998-2000
Title: The Innovations of Peter N McLaine
Introduction
Peter N McLaine is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of medical science, particularly in the treatment of bacterial infections. With a total of two patents to his name, McLaine's work focuses on addressing critical health issues.
Latest Patents
McLaine's latest patents include innovative methods for the treatment of bacterial dysentery. These methods specifically target the neutralization of shiga-like toxins (SLT) associated with enteric E. coli infections. His research aims to inhibit the progression of these infections into hemolytic uremic syndrome (HUS), a serious condition that can lead to kidney failure.
Career Highlights
Throughout his career, McLaine has been associated with Synsorb Biotech, Inc., a company dedicated to advancing biotechnological solutions. His work has been instrumental in developing therapies that address significant health challenges.
Collaborations
McLaine has collaborated with esteemed colleagues such as David J Rafter and Bradley G Thompson. These partnerships have enhanced the scope and impact of his research, contributing to advancements in medical treatments.
Conclusion
Peter N McLaine's contributions to medical science through his patents and collaborations highlight his commitment to improving health outcomes. His innovative approaches to treating bacterial dysentery demonstrate the importance of research in addressing public health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.